Status:
UNKNOWN
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment
Lead Sponsor:
University of Sao Paulo
Conditions:
Infertility
Eligibility:
FEMALE
21-38 years
Phase:
PHASE3
Brief Summary
This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (I...
Detailed Description
The aim of this study is to evaluate the efficacy of a GnRH agonist in preventing the functional rescue of corpus luteum in women submitted to controlled ovarian stimulation with administration of hCG...
Eligibility Criteria
Inclusion
- age \>21 and \< 38 years old
- polycystic ovarian syndrome
- risk for ovarian hyperstimulation syndrome
Exclusion
- recurrent abortion
- endometriosis
- more than 3 IVF failures
- use of oral contraceptive pills in the preceding 3 months
- low response to gonadotropins
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00948805
Start Date
January 1 2009
End Date
July 1 2010
Last Update
July 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assisted Reproduction Center "Governor Mário Covas" of the Faculty of Medicine of the University of São Paulo
São Paulo, São Paulo, Brazil, 05403000